It provides non-invasive, pain-less screening of chronic diagnoses based on Eye Retina picture. Three simple steps. Less than 30 seconds. Comprehensive result.Launch Aireen Now
Demographic and socio-economic changes in the world enforcing change of Healthcare systems. Broadly Accessible diagnostics, remain only medical solution.
500,000,000 people; growth of 50% expected over the next 15yrs
196,000,000 people in 2020; increasing to 288,000,000 in 2040
From 76,000,000 to 111,800,000 is expected growth of global Glaucoma prevalence within next 20 years.
Only 1-in-4 people with Alzheimer’s disease have been diagnosed.
* Under development
Our personal goal is to become preferred A.I. provider improving early diagnosis of major diseases from Retina Eye images beyond human possibilites.
Aireen will provide early diagnostics of chronical diseases at Point-of-contact. At GP’s offices and even more at Optics and Pharmacy stores.
Evidence instead of claim. Results including details and annotation identified lesions.
Jan Hlaváček / CEO of Aireen